Section of Breast Imaging

Medicine & Life Sciences

1. Acceleration 8%
2. Allografts 29%
3. Alternative Complement Pathway 23%
4. Angiography 13%
5. Anxiety 15%
6. Appendicitis 19%
7. Arm 14%
8. Aspartic Acid 17%
9. Atherosclerosis 10%
10. Biopsy 54%
11. Breast 100%
12. Breast Neoplasms 44%
13. Burkitt Lymphoma 20%
14. Cattle 13%
15. Cerebral Blood Volume 22%
16. Cerebral Hemorrhage 18%
17. Child 17%
18. Complement Activation 52%
19. Complement C3b 30%
20. complement C4d 7%
21. Computed Tomography Angiography 29%
22. Confidence Intervals 15%
23. Coracoid Process 9%
24. Cost Savings 11%
25. Costs and Cost Analysis 10%
26. Cyclosporine 15%
27. Data Systems 10%
28. Dibenz(b,f)(1,4)oxazepine-10(11H)-carboxylic acid, 8-chloro-, 2-acetylhydrazide 7%
29. Digital Subtraction Angiography 40%
30. Early Detection of Cancer 16%
31. Eicosapentaenoic Acid 20%
32. Extracorporeal Membrane Oxygenation 25%
33. Fibroadenoma 22%
34. Fistula 15%
35. fluciclovine F-18 31%
36. Glioma 15%
37. Gynecomastia 23%
38. Head 24%
39. Health 8%
40. Health Insurance Portability and Accountability Act 18%
41. Heart Transplantation 17%
42. Hemorrhage 10%
43. Hospital Emergency Service 19%
44. Image-Guided Biopsy 50%
45. Immunoglobulin Heavy Chains 22%
46. Informed Consent 25%
47. Isoprostanes 24%
48. Kidney 18%
49. Lung 9%
50. Magnetic Resonance Imaging 16%
51. Magnetic Resonance Spectroscopy 14%
52. Mammography 96%
53. Maximal Respiratory Pressures 23%
54. Monosomy 1p Chromosome 1 27%
55. Multiple Sclerosis 7%
56. Muromonab-CD3 22%
57. Muscle Strength 17%
58. Music 18%
59. Neck 12%
60. Neoplasms 26%
61. Nerve Block 19%
62. Neurotransmitter Agents 14%
63. Neutrophils 7%
64. Nose 8%
65. Nurses 12%
66. Optical Tomography 25%
67. Orthopedics 12%
68. Osteosarcoma 17%
69. Pancreas 9%
70. Pancreatitis 16%
71. Pediatrics 21%
72. Perfusion 12%
73. Phyllodes Tumor 24%
74. Prospective Studies 12%
75. Prostaglandins 7%
76. Prostatic Neoplasms 13%
77. Radiofrequency Ablation 9%
78. Radiologists 36%
79. Radiology 16%
80. ramatroban 8%
81. Randomized Controlled Trials 12%
82. Receptors, Prostaglandin E, EP1 Subtype 7%
83. Recurrence 9%
84. Research Ethics Committees 17%
85. Respiratory Muscles 20%
86. Retina 14%
87. Retrospective Studies 13%
88. ROC Curve 9%
89. Sharks 24%
90. SQ 29548 7%
91. Subclavian Steal Syndrome 12%
92. Syncope 18%
93. Therapeutics 7%
94. Thorax 17%
95. Tomography 16%
96. Transplant Recipients 20%
97. Transplants 7%
98. Ultrasonography 13%
99. Vertebral Artery 9%